Technical Analysis for EQ - Equillium, Inc.

Grade Last Price % Change Price Change
grade F 3.4905 -4.37% -0.16
EQ closed down 4.37 percent on Friday, November 15, 2019, on 10 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Up
See historical EQ trend table...

Date Alert Name Type % Chg
Fell Below 50 DMA Bearish 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
Inside Day Range Contraction 0.00%
Crossed Above 20 DMA Bullish -4.37%
Crossed Above 50 DMA Bullish -4.37%
180 Bullish Setup Bullish Swing Setup -4.37%
Pocket Pivot Bullish Swing Setup -4.37%
Volume Surge Other -4.37%

Older signals for EQ ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Equillium is a biotechnology company leveraging deep understanding of immunobiology to develop products to treat severe autoimmune and inflammatory disorders with high unmet medical need. Equillium’s initial product candidate, EQ001 (itolizumab), is a clinical-stage, first-in-class monocolonal antibody that selectively targets the novel immune checkpoint receptor CD6 and is designed to modulate T cells that drive immuno-inflammation. Itolizumab is a clinically-validated therapeutic with a favorable safety and tolerability profile. Equillium plans to advance EQ001 into clinical development in multiple indications of high unmet medical need and believes EQ001 has the potential to be a best-in-class disease modifying therapeutic.
Medicine Biotechnology Health Immunology Immune System Antibody Autoimmunity Monoclonal Antibody Sutro Biopharma Glycoproteins
Is EQ a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 19.69
52 Week Low 2.555
Average Volume 38,592
200-Day Moving Average 5.3864
50-Day Moving Average 3.6162
20-Day Moving Average 3.3602
10-Day Moving Average 3.375
Average True Range 0.38
ADX 18.45
+DI 16.792
-DI 13.0918
Chandelier Exit (Long, 3 ATRs ) 2.77
Chandelier Exit (Short, 3 ATRs ) 3.695
Upper Bollinger Band 3.7174
Lower Bollinger Band 3.003
Percent B (%b) 0.68
BandWidth 21.260639
MACD Line -0.0573
MACD Signal Line -0.0961
MACD Histogram 0.0388
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.66
Resistance 3 (R3) 3.64 3.57 3.63
Resistance 2 (R2) 3.57 3.53 3.58 3.62
Resistance 1 (R1) 3.53 3.50 3.50 3.55 3.61
Pivot Point 3.46 3.46 3.44 3.47 3.46
Support 1 (S1) 3.42 3.42 3.39 3.44 3.37
Support 2 (S2) 3.35 3.39 3.36 3.36
Support 3 (S3) 3.31 3.35 3.35
Support 4 (S4) 3.33